| Form of presentation | Conference proceedings in international journals and collections |
| Year of publication | 2018 |
|
Gusev Oleg Aleksandrovich, author
Shagimardanova Elena Ilyasovna, author
|
| Other authors |
Nikitin Aleksey Georgievich |
|
Ananeva Anastasiya Viktorovna, postgraduate kfu
Shigapova Leylya Khuzzatovna, postgraduate kfu
|
| Bibliographic description in the original language |
Ananeva, A. Genetic testing to guide warfarin dosage in Russian Federation / A.Ananeva, L.Shigapova, A.Nikitin, M.Gordiev, E.Shagimardanova // Abstracts of the 52nd Annual Scientific Meeting of the European Society for Clinical Investigation "Precision medicine for healthy ageing". - 2018. - V.48. - I.1. - P.135. |
| Annotation |
Warfarin is widely prescribed anticoagulant in thromboembolic disorders, that acts by reducing the activity of vitamin K-dependent clotting
factors. The dose of warfarin should be adapted for each patient, based on individual properties and measurements: weight, height, ethnic
background and presence of SNPs in genes involved in warfarin metabolism. In this study, we aimed to determine the frequency of
clinically relevant SNP in CYP2C9 and VKORC1 in population of Tatarstan region in Russian Federation. |
| Keywords |
warfarin, polymorphism, next-generation sequencing (NGS) |
| Place of publication |
Барселона |
| Publishing house |
John Wiley & Sons Ltd |
| URL |
https://onlinelibrary.wiley.com/toc/13652362/2018/48/S1 |
| Please use this ID to quote from or refer to the card |
https://repository.kpfu.ru/eng/?p_id=182660&p_lang=2 |
Full metadata record  |
| Field DC |
Value |
Language |
| dc.contributor.author |
Gusev Oleg Aleksandrovich |
ru_RU |
| dc.contributor.author |
Shagimardanova Elena Ilyasovna |
ru_RU |
| dc.contributor.author |
Ananeva Anastasiya Viktorovna |
ru_RU |
| dc.contributor.author |
Shigapova Leylya Khuzzatovna |
ru_RU |
| dc.date.accessioned |
2018-01-01T00:00:00Z |
ru_RU |
| dc.date.available |
2018-01-01T00:00:00Z |
ru_RU |
| dc.date.issued |
2018 |
ru_RU |
| dc.identifier.citation |
Ananeva, A. Genetic testing to guide warfarin dosage in Russian Federation / A.Ananeva, L.Shigapova, A.Nikitin, M.Gordiev, E.Shagimardanova // Abstracts of the 52nd Annual Scientific Meeting of the European Society for Clinical Investigation "Precision medicine for healthy ageing". - 2018. - V.48. - I.1. - P.135. |
ru_RU |
| dc.identifier.uri |
https://repository.kpfu.ru/eng/?p_id=182660&p_lang=2 |
ru_RU |
| dc.description.abstract |
Warfarin is widely prescribed anticoagulant in thromboembolic disorders, that acts by reducing the activity of vitamin K-dependent clotting
factors. The dose of warfarin should be adapted for each patient, based on individual properties and measurements: weight, height, ethnic
background and presence of SNPs in genes involved in warfarin metabolism. In this study, we aimed to determine the frequency of
clinically relevant SNP in CYP2C9 and VKORC1 in population of Tatarstan region in Russian Federation. |
ru_RU |
| dc.language.iso |
ru |
ru_RU |
| dc.publisher |
John Wiley & Sons Ltd |
ru_RU |
| dc.subject |
warfarin |
ru_RU |
| dc.subject |
polymorphism |
ru_RU |
| dc.subject |
next-generation sequencing (NGS) |
ru_RU |
| dc.title |
Title Genetic testing to guide warfarin dosage in Russian Federation |
ru_RU |
| dc.type |
Conference proceedings in international journals and collections |
ru_RU |
|
RUS 
中文 
ES 
Sitemap
